Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA grant to WHO addresses counterfeiting

This article was originally published in The Tan Sheet

Executive Summary

FDA plans to award the World Health Organization $960,500 to build a global surveillance and monitoring system to root out counterfeit medicines, according to an Oct. 13 Federal Register notice. WHO would use the grant, requested in a single-source 1application, to identify risks in supply chains, standardize data collection among member states and harmonize analyses to identify counterfeit medicines. FDA may extend the grant, which will be from the agency's fiscal 2010 appropriation, for three more years for up to $847,500 annually

FDA plans to award the World Health Organization $960,500 to build a global surveillance and monitoring system to root out counterfeit medicines, according to an Oct. 13 Federal Register notice. WHO would use the grant, requested in a single-source 1 application, to identify risks in supply chains, standardize data collection among member states and harmonize analyses to identify counterfeit medicines. FDA may extend the grant, which will be from the agency's fiscal 2010 appropriation, for three more years for up to $847,500 annually.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS104603

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel